Literature DB >> 7664022

New insights into the mode of action of anti-inflammatory drugs.

J R Vane1, R M Botting.   

Abstract

The discovery of a second cyclooxygenase has provided fresh impetus to the search for new anti-inflammatory drugs. The second enzyme is effectively absent from healthy tissues but its levels rise dramatically during inflammation. It can be induced in migratory cells by bacterial lipopolysaccharide, cytokines and growth factors. The constitutive cyclooxygenase-1 (COX-1) can thus be considered a "housekeeping" enzyme, in contrast to cyclooxygenase-2 (COX-2) which is activated by tissue damage. Both enzymes have a molecular weight of around 70 kDa and similar Km and Vmax values for their reaction with arachidonic acid. Several non steroid anti-inflammatory drugs which have more than 1,000 fold selectivity for COX-2 over COX-1 are in the early stages of drug development.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7664022     DOI: 10.1007/bf01630479

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  86 in total

1.  INHIBITION OF RAT BRAIN GLUTAMATE DECARBOXYLASE ACTIVITY BY SALICYLATE IN VITRO.

Authors:  B J GOULD; M J SMITH
Journal:  J Pharm Pharmacol       Date:  1965-01       Impact factor: 3.765

2.  INHIBITION OF DEHYDROGENASES BY SALICYLATE.

Authors:  W J HINES; M J SMITH
Journal:  Nature       Date:  1964-01-11       Impact factor: 49.962

3.  Ability of some antirheumatic drugs to uncouple oxidative phosphorylation.

Authors:  M W WHITEHOUSE; J M HASLAM
Journal:  Nature       Date:  1962-12-29       Impact factor: 49.962

4.  Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity.

Authors:  B P Wallner; R J Mattaliano; C Hession; R L Cate; R Tizard; L K Sinclair; C Foeller; E P Chow; J L Browing; K L Ramachandran
Journal:  Nature       Date:  1986 Mar 6-12       Impact factor: 49.962

5.  Drugs which inhibit prostaglandin biosynthesis.

Authors:  R J Flower
Journal:  Pharmacol Rev       Date:  1974-03       Impact factor: 25.468

6.  Prostaglandins, aspirin-like drugs and analgesia.

Authors:  S H Ferreira
Journal:  Nat New Biol       Date:  1972-12-13

7.  Relationship between the prevention of rat gastric erosions and the inhibition of acid secretion by prostaglandins.

Authors:  B J Whittle
Journal:  Eur J Pharmacol       Date:  1976-12       Impact factor: 4.432

8.  Total content of prostaglandin F2 alpha in the endometrium and myometrium from various sections of the porcine uterine horn during the estrous cycle.

Authors:  S Stefanczyk-Krzymowska; B Szafranska; T Kaminski; T Krzymowski
Journal:  Prostaglandins       Date:  1994-08

9.  Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide.

Authors:  J Stadler; M Stefanovic-Racic; T R Billiar; R D Curran; L A McIntyre; H I Georgescu; R L Simmons; C H Evans
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

10.  NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro.

Authors:  N Futaki; S Takahashi; M Yokoyama; I Arai; S Higuchi; S Otomo
Journal:  Prostaglandins       Date:  1994-01
View more
  95 in total

Review 1.  Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer's disease.

Authors:  P L McGeer
Journal:  Drugs Aging       Date:  2000-07       Impact factor: 3.923

2.  A new cationic palladium(II) dithiocarbamate exhibits anti-inflammatory, analgesic, and antipyretic activities through inhibition of inflammatory mediators in in vivo models.

Authors:  Muhammad Naveed; Shahan Zeb Khan; Sara Zeeshan; Adnan Khan; Bushra Shal; Ayesha Atiq; Hussain Ali; Rahim Ullah; Salman Khan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-04-09       Impact factor: 3.000

3.  Multi-pathway integrated adjustment mechanism of licorice flavonoids presenting anti-inflammatory activity.

Authors:  Xiaomeng Yu; Yongrui Bao; Xiansheng Meng; Shuai Wang; Tianjiao Li; Xin Chang; Weifeng Xu; Guanlin Yang; Tao Bo
Journal:  Oncol Lett       Date:  2019-09-04       Impact factor: 2.967

4.  Management of Inflammatory Pain with Selective COX-2 Inhibitors: Promises and Facts.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

Review 5.  Glucocorticoids in Alzheimer's disease. The story so far.

Authors:  P S Aisen; G M Pasinetti
Journal:  Drugs Aging       Date:  1998-01       Impact factor: 3.923

Review 6.  Nonsteroidal anti-inflammatory analgesics in pain management in dogs and cats.

Authors:  K A Mathews
Journal:  Can Vet J       Date:  1996-09       Impact factor: 1.008

7.  Is there a COX-fight during inflammation?

Authors:  M J Parnham
Journal:  Inflamm Res       Date:  1998-02       Impact factor: 4.575

8.  The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells. Dependence on the availability of downstream targets.

Authors:  K E Bornfeldt; J S Campbell; H Koyama; G M Argast; C C Leslie; E W Raines; E G Krebs; R Ross
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

Review 9.  [New non-steroidal anti-rheumatic drugs: selective inhibitors of inducible cyclooxygenase].

Authors:  D O Stichtenoth; H Zeidler; J C Frölich
Journal:  Med Klin (Munich)       Date:  1998-07-15

10.  Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations.

Authors:  Saida Mebarek; Abdelkarim Abousalham; David Magne; Le Duy Do; Joanna Bandorowicz-Pikula; Slawomir Pikula; René Buchet
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.